RELAPSED CANCER

Clinical trials for RELAPSED CANCER explained in plain language.

Never miss a new study

Get alerted when new RELAPSED CANCER trials appear

Sign up with your email to follow new studies for RELAPSED CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New hope for brain cancer? experimental drug LMP744 targets recurrent glioblastoma

Disease control Not yet recruiting

This early-stage trial tests a new drug called LMP744 in 40 adults whose glioblastoma (a type of brain cancer) has come back after standard treatment. The drug is given through a vein for 5 days each month for up to a year. The goal is to see if it can shrink tumors or delay canc…

Matched conditions: RELAPSED CANCER

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control

Last updated May 11, 2026 20:49 UTC

RELAPSED CANCER

Get alerted when new RELAPSED CANCER trials appear

New hope for brain cancer? experimental drug LMP744 targets recurrent glioblastoma